Adcetris is a medication that is manufactured by Seattle Genetics, Inc. and it was originally approved for use in the United States by the FDA in August of 2011. Adcetris is prescribed to patients who need help treating conditions that include Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma. At the time at which Adcetris was granted approval for use by the FDA, one person who was using this medication had already been diagnosed with PML, as was documented on the warning literature. However, recent reports have indicated that two other people using Adcetris have since been diagnosed with PML, which is a dangerous infection of the brain that can be fatal. As such, the FDA has taken steps to make the public aware of this potential danger. If you or a loved one has used Adcetris and been harmed as a result, you need to take steps to contact experienced Adcetris lawyers today to schedule a free initial consultation. Doing so will provide you with the opportunity to have your legal rights and potential options thoroughly explored and clarified.
As stated above, there was one diagnosed case of PML in existence with someone who had been using Adcetris at the time it was approved in August of 2011. Since then, two additional diagnoses of PML have been made, prompting public action by the FDA. PML is a dangerous brain infection that can be fatal, and the common symptoms associated with PML include:
If you have been using Adcetris to treat health conditions such as Hodgkin lymphoma or systemic anaplastic large cell lymphoma and you’ve experienced any of these symptoms, you need to seek a full medical evaluation as soon as possible. You should take the same step if you are experiencing any other potential side effects.
Given the recent news regarding two additional diagnoses of PML, the FDA has taken two steps related directly to this potential problem and another step that relates to the use of Adcetris but is not directly related to the risk of being diagnosed with PML. These steps have been taken in an attempt to alert the public of the potential dangers they could face if they trust Adcetris to treat their already-serious health conditions. Specifically, one step that the FDA has taken in response to potential Adcetris side effects involves issuing a public warning to physicians across the United States regarding the news that has been received regarding the diagnoses of PML by those who were using this medication. In addition, the FDA has added a ‘Boxed Warning’ to containers of Adcetris that are designed to clearly warn those who may use this medication of the risks they could be facing.
In another step related to Adcetris but not to the diagnoses of PML, the FDA has issued a ‘Contraindication Warning’ that relates to the simultaneous use of Adcetris with the cancer drug bleomycin due to increased risk of pulmonary (lung) toxicity. Patients using these medications should also seek medical attention.
If you or someone you love has been using Adcetris and you’ve contracted PML as a result, you need to take immediate steps to protect your legal rights. You can do so by seeking the help of experienced Adcetris attorneys who have been holding large drug companies accountable for the dangerous medications they produce for many years. There are laws in existence that allow injured consumers to stand up for their legal rights even against enormous corporations, as these pharmaceutical companies such as Seattle Genetics need to answer for the irreparable harm they have done to unsuspecting consumers from time to time by way of producing dangerous medications. People who have been harmed in this manner could recover compensation that helps make them whole for losses that include additional medical costs incurred because of using Adcetris, lost income that was missed because of an illness caused by Adcetris and recovery for pain and suffering based on the loss of quality of life that may have been caused by Adcetris. If any of these scenarios sound familiar, contact an Adcetris lawyer today to schedule a free initial consultation.